Product Code: ETC5300885 | Publication Date: Nov 2023 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 | |
The Gambia Pharmaceuticals Market is poised for steady growth rate improvements from 2025 to 2029. Commencing at 4.16% in 2025, growth builds up to 4.98% by 2029.
Gambia's Pharmaceuticals market is anticipated to experience a stable growth rate of 4.37% by 2027, reflecting trends observed in the largest economy Egypt, followed by South Africa, Ethiopia, Algeria and Nigeria.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Gambia Pharmaceuticals Market Overview |
3.1 Gambia Country Macro Economic Indicators |
3.2 Gambia Pharmaceuticals Market Revenues & Volume, 2021 & 2031F |
3.3 Gambia Pharmaceuticals Market - Industry Life Cycle |
3.4 Gambia Pharmaceuticals Market - Porter's Five Forces |
3.5 Gambia Pharmaceuticals Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Gambia Pharmaceuticals Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.7 Gambia Pharmaceuticals Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Gambia Pharmaceuticals Market Revenues & Volume Share, By Drug Classification, 2021 & 2031F |
3.9 Gambia Pharmaceuticals Market Revenues & Volume Share, By Mode of Purchase, 2021 & 2031F |
4 Gambia Pharmaceuticals Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diseases and health conditions in Gambia |
4.2.2 Government initiatives to improve healthcare infrastructure and access to medicines |
4.2.3 Growing healthcare expenditure and rising disposable income in the country |
4.3 Market Restraints |
4.3.1 Limited availability of skilled healthcare professionals |
4.3.2 Lack of regulatory framework and enforcement in the pharmaceutical sector |
4.3.3 High dependency on imported pharmaceutical products leading to supply chain challenges |
5 Gambia Pharmaceuticals Market Trends |
6 Gambia Pharmaceuticals Market Segmentations |
6.1 Gambia Pharmaceuticals Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Gambia Pharmaceuticals Market Revenues & Volume, By Pharmaceutical Drugs, 2021-2031F |
6.1.3 Gambia Pharmaceuticals Market Revenues & Volume, By Biologics, 2021-2031F |
6.2 Gambia Pharmaceuticals Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Gambia Pharmaceuticals Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.2.3 Gambia Pharmaceuticals Market Revenues & Volume, By Retail Pharmacies/ Drug Stores, 2021-2031F |
6.2.4 Gambia Pharmaceuticals Market Revenues & Volume, By Others, 2021-2031F |
6.3 Gambia Pharmaceuticals Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Gambia Pharmaceuticals Market Revenues & Volume, By Oral, 2021-2031F |
6.3.3 Gambia Pharmaceuticals Market Revenues & Volume, By Parenteral, 2021-2031F |
6.3.4 Gambia Pharmaceuticals Market Revenues & Volume, By Others, 2021-2031F |
6.4 Gambia Pharmaceuticals Market, By Drug Classification |
6.4.1 Overview and Analysis |
6.4.2 Gambia Pharmaceuticals Market Revenues & Volume, By Branded Drugs, 2021-2031F |
6.4.3 Gambia Pharmaceuticals Market Revenues & Volume, By Generic Drugs, 2021-2031F |
6.5 Gambia Pharmaceuticals Market, By Mode of Purchase |
6.5.1 Overview and Analysis |
6.5.2 Gambia Pharmaceuticals Market Revenues & Volume, By Prescription-Based Drugs, 2021-2031F |
6.5.3 Gambia Pharmaceuticals Market Revenues & Volume, By Over-The-Counter Drugs, 2021-2031F |
7 Gambia Pharmaceuticals Market Import-Export Trade Statistics |
7.1 Gambia Pharmaceuticals Market Export to Major Countries |
7.2 Gambia Pharmaceuticals Market Imports from Major Countries |
8 Gambia Pharmaceuticals Market Key Performance Indicators |
8.1 Percentage increase in the number of healthcare facilities and pharmacies in Gambia |
8.2 Average waiting time for patients to access essential medicines |
8.3 Percentage of population covered by health insurance |
8.4 Number of clinical trials and research studies conducted on locally produced pharmaceuticals |
8.5 Percentage of GDP allocated to healthcare spending |
9 Gambia Pharmaceuticals Market - Opportunity Assessment |
9.1 Gambia Pharmaceuticals Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Gambia Pharmaceuticals Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.3 Gambia Pharmaceuticals Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Gambia Pharmaceuticals Market Opportunity Assessment, By Drug Classification, 2021 & 2031F |
9.5 Gambia Pharmaceuticals Market Opportunity Assessment, By Mode of Purchase, 2021 & 2031F |
10 Gambia Pharmaceuticals Market - Competitive Landscape |
10.1 Gambia Pharmaceuticals Market Revenue Share, By Companies, 2024 |
10.2 Gambia Pharmaceuticals Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |